1199P Dose modification for the management of CNS adverse events in the phase III CROWN study of lorlatinib in non-small cell lung cancer (NSCLC)
Solomon, B.J., Mok, T.S.K., Hayashi, H., Bearz, A., Penkov, K.D., Wu, Y-L., Arrieta, O., Calella, A.M., Peltz, G., Polli, A., Thurm, H., Bauer, T.M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
LBA2 Lorlatinib vs crizotinib in the first-line treatment of patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC): Results of the phase III CROWN study
Solomon, B., Bauer, T.M., De Marinis, F., Felip, E., Goto, Y., Liu, G., Mazieres, J., Kim, D-W., Mok, T., Polli, A., Thurm, H., Calella, A.M., Peltz, G., Shaw, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1197P First-line lorlatinib versus crizotinib in ALK-positive non-small cell lung cancer: Asian subgroup analysis of CROWN
Zhou, Q., Kim, H.R., Soo, R., Chang, G-C., Chiu, C-H., Hayashi, H., Kim, S-W., Teraoka, S., Goto, Y., Zhou, J., Lee, V.H.F., Han, B., Ho, J.C.M., Kim, D-W., Lin, C-C., Lu, S., Polli, A., Calella, A.M., Mok, T.S.K., Wu, Y-L.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Apolipoprotein E and Intronic Polymorphism of Presenilin 1 and Alpha-1-Antichymotrypsin in Alzheimer’s Disease and Vascular Dementia
Rodriguez Martin, T., Calella, A.M., Silva, S., Munna, E., Modena, P., Chiesa, R., Terrevazzi, S., Ruggieri, R.M., Palermo, R., Piccoli, F., Confalonieri, R., Tiraboschi, P., Fragiacomo, C., Quadri, P., Lucca, U., Forloni, G.
Published in Dementia and geriatric cognitive disorders (01.09.2000)
Published in Dementia and geriatric cognitive disorders (01.09.2000)
Get full text
Journal Article